Danish companies are among the early foreign investors expressing serious interest in the new Johor-Singapore Special Economic Zone (JS-SEZ), with particular focus on the medical and pharmaceutical sectors, according to the Iskandar Regional Development Authority (IRDA).
Speaking at the 32nd National Real Estate Convention on Thursday 17 April 2025, Maimunah Jaffar, IRDA’s director of strategic driver, said Danish firms — along with companies from China and Australia — are exploring opportunities to establish integrated operations in the zone.
“The ones that come frequently with their delegates, and especially when the parent companies are involved, indicate serious intent,” says Maimunah. “These players typically bring an entire ecosystem with them.”
The JS-SEZ is supported by the recently launched Iskandar Malaysia Facilitation Centre, a one-stop service hub established in February to streamline investment applications, approvals, and aftercare processes. Since its inception, the centre has received over 250 enquiries from potential investors.
Some investment announcements could be made within 2025, Maimunah added. Danish companies are seen as strong contenders in pharmaceuticals and medical device manufacturing — sectors the IRDA is actively targeting with tailored incentives.
Foreign investors are reportedly exploring large-scale operations, with some eyeing up to 1,000 acres of space and considering relocating supporting companies, forming sector-based clusters. Interest is also growing among embassy and business representatives of firms currently based in Singapore.
The JS-SEZ aims to secure 50 major investment projects within its first five years.
Source: The Edge
